Milestone Pharmaceuticals Inc. SEC filings
Every EDGAR filing for Milestone Pharmaceuticals Inc. (MIST), newest first, with AI summaries and stories.
- Ticker
- MIST
- CIK
- 1408443
- Latest filing
- Sep 4
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE NOTABLE10-QMilestone Pharmaceuticals Inc.MISTLIVE ROUTINESCHEDULE 13GMilestone Pharmaceuticals Inc.MISTLIVE Ownership stake disclosure by Pavaki Capital Management LLC
Pavaki Capital Management LLC, filed by
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE ROUTINE4Milestone Pharmaceuticals Inc.MISTLIVE 7 insider filings
Stuart Duty, insider filing for MIST
Show all 7
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
Stuart Duty, reporting
ROUTINEEFFECTMilestone Pharmaceuticals Inc.MISTLIVE ROUTINESCHEDULE 13G/AMilestone Pharmaceuticals Inc.MISTLIVE Ownership stake disclosure by RTW INVESTMENTS, LP (amended)
RTW INVESTMENTS, LP, filed by
ROUTINES-3Milestone Pharmaceuticals Inc.MISTLIVE ROUTINESCHEDULE 13G/AMilestone Pharmaceuticals Inc.MISTLIVE Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE NOTABLE10-QMilestone Pharmaceuticals Inc.MISTLIVE ROUTINEARSMilestone Pharmaceuticals Inc.MISTLIVE ROUTINEDEFA14AMilestone Pharmaceuticals Inc.MISTLIVE ROUTINEDEF 14AMilestone Pharmaceuticals Inc.MISTLIVE ROUTINE4Milestone Pharmaceuticals Inc.MISTLIVE Joseph Oliveto, insider filing for MIST
Joseph Oliveto, reporting
ROUTINE144Milestone Pharmaceuticals Inc.MISTLIVE Joseph Oliveto, planned sale of MIST shares
Joseph Oliveto, reporting
ROUTINESCHEDULE 13G/AMilestone Pharmaceuticals Inc.MISTLIVE Ownership stake disclosure by Trails Edge Capital Partners, LP (amended)
Trails Edge Capital Partners, LP, filed by
ROUTINE3Milestone Pharmaceuticals Inc.MISTLIVE David I. Sandoval, new insider at MIST
David I. Sandoval, reporting
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE NOTABLE10-KMilestone Pharmaceuticals Inc.MISTLIVE ROUTINE4/AMilestone Pharmaceuticals Inc.MISTLIVE 5 insider filings
David Bharucha, insider filing for MIST (amended)
Show all 5
- 4/AInsider filing for MIST (amended)
- 4/AInsider filing for MIST (amended)
- 4/AInsider filing for MIST (amended)
- 4/AInsider filing for MIST (amended)
- 4/AInsider filing for MIST (amended)
David Bharucha, reporting
ROUTINE4Milestone Pharmaceuticals Inc.MISTLIVE 5 insider filings
Lorenz Muller, insider filing for MIST
Show all 5
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
Lorenz Muller, reporting
ROUTINE4Milestone Pharmaceuticals Inc.MISTLIVE 5 insider filings
Amit Hasija, insider filing for MIST
Show all 5
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
- 4Insider filing for MIST
Amit Hasija, reporting
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE ROUTINE4Milestone Pharmaceuticals Inc.MISTLIVE Joseph Oliveto, insider filing for MIST
Joseph Oliveto, reporting
ROUTINE144Milestone Pharmaceuticals Inc.MISTLIVE Joseph Oliveto, planned sale of MIST shares
Joseph Oliveto, reporting
ROUTINE144Milestone Pharmaceuticals Inc.MISTLIVE Joseph Oliveto, planned sale of MIST shares
Joseph Oliveto, reporting
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE ROUTINESCHEDULE 13GMilestone Pharmaceuticals Inc.MISTLIVE Ownership stake disclosure by Propel Bio Management, LLC
Propel Bio Management, LLC, filed by
ROUTINE8-KMilestone Pharmaceuticals Inc.MISTLIVE